Latest research news are now in your pocket

Thursday, 16 November 2017

Drug repositioning paves a new pathway to fight antibiotic resistance.

Have you heard a medicine given to treat seasonal fever finds it use in cancer treatment???
Well, this can be true using drug repositioning or drug repurposing. It is application of known drugs to treat new infections and diseases. We are all aware of the frantic game of drug-resistance. Researchers around the world are leaving no stone unturned to take a control over the situation. Biomedical scientist Thomas Vorup-Jensen at the Aarhus University have found that drug repirposing can solve some of the problem. He and his team have found that the drug Glatiramer Acetate or Copaxone that is used to treat multiple sclerosis can now eliminate gram negative bacteria, often resistant to antibiotics.

The study has been published in the journal Nature and the summary can be read here


Post a Comment

Copyright © We The Microbiologist Research News | Powered by Blogger
Design by SimpleWpThemes | Blogger Theme by